Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug

NYT Health, 20 April 2015
Author: Katie Thomas
“The drug maker Teva Pharmaceutical Industries said on Monday that it had agreed to pay $512 million to settle claims that a subsidiary, Cephalon, paid generic manufacturers to keep their own cheaper versions of a drug off the market, a practice that the Supreme Court ruled in 2013 could be illegal in some cases.”
Find article here.